Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
3.725
+0.205 (5.82%)
Mar 31, 2025, 1:39 PM EDT - Market open
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $207.16 million as of March 31, 2025. Its market cap has decreased by -28.01% in one year.
Market Cap
207.16M
Enterprise Value
-13.09M
1-Year Change
-28.01%
Ranking
Category
Stock Price
$3.73
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $207.16M, a decrease of -63.36%. That is a compound annual growth rate of -20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 195.76M | -25.40% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.66B |
| UnitedHealth Group | 473.39B |
| Johnson & Johnson | 394.97B |
| AbbVie | 363.63B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 227.58B |
| Merck & Co. | 226.28B |
| AstraZeneca | 225.00B |